BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28592047)

  • 1. [The update of emerging targeted therapies of lung cancer].
    Shang CC; Zhang L
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):447-449. PubMed ID: 28592047
    [No Abstract]   [Full Text] [Related]  

  • 2. How Targeted Therapies Are Changing Treatment for Non-Small Cell Lung Cancer.
    Becze E
    ONS Connect; 2016 Feb; 31(2):24-5. PubMed ID: 26930998
    [No Abstract]   [Full Text] [Related]  

  • 3. The lung and winding road: twists and turns on the way to personalized NSCLC therapy.
    Milella M
    Curr Pharm Des; 2014; 20(24):3861-2. PubMed ID: 24191957
    [No Abstract]   [Full Text] [Related]  

  • 4. A tabulated summary of targeted and biologic therapies for non-small-cell lung cancer.
    Somaiah N; Simon NG; Simon GR
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S342-68. PubMed ID: 23160320
    [No Abstract]   [Full Text] [Related]  

  • 5. Update on HER1-3 in advanced non-small-cell lung cancer.
    Horn L; Lovly C
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S369-71. PubMed ID: 23160321
    [No Abstract]   [Full Text] [Related]  

  • 6. An update on biomarkers for kinase inhibitor response in non-small-cell lung cancer.
    Ku BM; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
    Expert Rev Mol Diagn; 2017 Oct; 17(10):933-942. PubMed ID: 28838271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylinositol-3-kinase pathway.
    Reckamp KL
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S383-4. PubMed ID: 23160326
    [No Abstract]   [Full Text] [Related]  

  • 8. New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer.
    Zarogoulidis P; Yarmus L; Zarogoulidis K
    Ther Deliv; 2013 Oct; 4(10):1221-3. PubMed ID: 24116905
    [No Abstract]   [Full Text] [Related]  

  • 9. Biomarker strategy in lung cancer.
    Esencay M; Watson A; Mukherjee K; Hanicq D; Gubernick SI
    Nat Rev Drug Discov; 2018 Jan; 17(1):13-14. PubMed ID: 28959953
    [No Abstract]   [Full Text] [Related]  

  • 10. Phosphatidykinosital 3-kinase and mammalian target of rapamycin pathway in non-small-cell lung cancer.
    Massarelli E; Papadimitrakopoulou VA
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S379-82. PubMed ID: 23160325
    [No Abstract]   [Full Text] [Related]  

  • 11. Personalised medicine for nonsmall cell lung cancer.
    Mascaux C; Tomasini P; Greillier L; Barlesi F
    Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29141962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp90 inhibitors.
    Pillai RN; Ramalingam SS
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S407-8. PubMed ID: 23160336
    [No Abstract]   [Full Text] [Related]  

  • 13. [Not Available].
    Evers G; Mohr M; Kerkhoff A; Lenz G; Wiewrodt R; Schmidt LH
    Dtsch Med Wochenschr; 2017 Oct; 142(20):1531-1534. PubMed ID: 29017211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular targeted agents and biologic therapies for non-small cell lung cancer.
    Somaiah N; Simon GR
    J Thorac Oncol; 2010 Dec; 5(12 Suppl 6):S434-54. PubMed ID: 21102235
    [No Abstract]   [Full Text] [Related]  

  • 15. [Improving the internal medical care to set up a leading model for precision medicine development in lung cancer].
    Han BH
    Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):81-85. PubMed ID: 28219199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAPK pathway: a potential target for the treatment of non-small-cell lung carcinoma.
    Pradhan R; Singhvi G; Dubey SK; Gupta G; Dua K
    Future Med Chem; 2019 Apr; 11(8):793-795. PubMed ID: 30994024
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeting MEK for the treatment of non-small-cell lung cancer.
    Goldman JW; Garon EB
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S377-8. PubMed ID: 23160324
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeted agents in the management of small cell lung cancer - present and future.
    Srivastava R; Lebowicz Y; Jamil MO
    Drugs Today (Barc); 2018 Aug; 54(8):479-488. PubMed ID: 30209442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting fibroblast growth factor receptor and discoidin domain receptor 2 in non-small-cell lung cancer.
    Riess JW; Neal JW
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S385-6. PubMed ID: 23160327
    [No Abstract]   [Full Text] [Related]  

  • 20. Doubling down with inhibitors of Notch and Hedgehog signaling pathways.
    Weiss GJ
    J Thorac Oncol; 2012 Dec; 7(16 Suppl 5):S409-10. PubMed ID: 23160337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.